Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Florida Man Claims Actos Caused Bladder Cancer

Filed June 24th, 2013 Joshua Sophy

A Florida man has become the latest to claim that taking the type 2 diabetes drug Actos has resulted in bladder cancer.

His case is the latest to be consolidated as part of a growing federal multidistrict litigation (MDL), which now has thousands of similar lawsuits that claim taking Actos has resulted in life-threatening bladder cancer. This lawsuit, along with the others, is filed in U.S. District Court for the Western District of Louisiana. Takeda Pharmaceuticals and Eli Lilly are named as Defendants in the lawsuits.

The Florida man is being represented by the national law firm of Parker Waichman LLP. The firm has been investigating claims that Actos causes bladder cancer for several years, even before the U.S. Food and Drug Administration finally warned that taking Actos at high doses or over a long period of time significantly increased a person’s chances of developing bladder cancer.

According to a statement from Parker Waichman, the plaintiff in this latest lawsuit began taking Actos to treat type 2 diabetes in January 2002. He took the drug for more than three years, until April 2005, when he was diagnosed with bladder cancer. According to the Complaint, both Takeda and Eli Lilly were aware of the risks associated with the drug, but continued to market it as safe and effective in the treatment of diabetes in order to continue Actos’ strong sales record.

Based on our previous accounts, there is ample evidence that taking Actos at high doses or for long periods of time could increase a person’s chances of developing life-threatening bladder cancer. Notable among those studies is a report appearing in the British Medical Journal last May that showed diabetics taking Actos were twice as likely to develop bladder cancer than someone on another diabetes medication.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!